Entity catalog
Medtronic PLC logo
Corporation · Context entityPublished

Medtronic PLC

Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients in the United States, Ireland, and internationally. It operates through three segments: The Cardiovascular Portfolio, Neuroscience Portfolio, and Medical Surgical Portfolio. The Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves, surgical valve replacement and repair products, endovascular stent grafts and accessories, and transcatheter pulmonary valves, left atrial appendage exclusion systems, extracorporeal membrane oxygenation (ECMO) systems and percutaneous coronary intervention products, percutaneous angioplasty balloons, and endovenous products. The Neuroscience Portfolio segment offers medical devices and implants, biologic solutions, spinal cord stimulation and brain modulation systems, implantable drug infusion systems, and interventional products, as well as nerve ablation system under the Accurian name. This segment offers its products for spinal surgeons, neurosurgeons, neurologists, pain management specialists, anesthesiologists, orthopedic surgeons, urologists, urogynecologists, and interventional radiologists, as well as ear, nose, and throat specialists, and energy surgical instruments. The Medical Surgical Portfolio segment offers surgical stapling devices, vessel sealing instruments, wound closure and electrosurgery products, AI-powered surgical video and analytics platform, robotic-assisted surgery products, hernia mechanical devices, mesh implants, gynecology products, gastrointestinal and hepatologic diagnostics and therapies, and therapies to treat diseases and conditions, and patient monitoring and airway management products, as well as insulin pumps and consumables, continuous glucose monitoring sys

Corporation
Organization profile
Chief executive
Mr. Geoffrey Straub Martha
Employees
95,000
Sector
Healthcare
Industry
Medical Devices
Country
US
IPO date
1978-01-13
Official website

Profile observed 2026-09-08 03:07:54.252081+00 via eodhd.

Published forecasts

Forecasts are available for Medtronic PLC's listed securities

A corporation provides context; forecasts attach to the exact market security and forecast target. Choose a related security below.

Identifiers & semantic identity

External identifiers, stable Library identity, and semantic-web assertions describe the same governed entity.

External and market identifiers
Wikidata ID
Q642189
Google Knowledge Graph MID
/m/03z4j3
iPulse entity ID
fundsubj_49ee4d81-28d3-5907-83c1-a09251c2f6bb
Official Website Url
https://www.medtronic.com/

Relationship graph

2D · draggable

The blue forecastable node can receive forecast targets. Green context nodes explain who issues, owns, or hosts it.

Forecastable entity Context entity